Short term ex-vivo expansion of circulating head and neck tumour cells

Oncotarget

Volumn 7, Issue 37, 2016, Pages 60101-60109

  Kulasinghe, Arutha ^a,d   Perry, Chris ^b   Warkiani, Majid E ^c   Blick, Tony ^a,d   Davies, Anthony ^a,d   O'Byrne, Ken ^a,d   Thompson, Erik W ^a,d   Nelson, Colleen C ^a,d   Vela, Ian ^a,b,d   Punyadeera, Chamindie ^a,d  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d TRANSLATIONAL RESEARCH INSTITUTE   (Australia)

Author keywords

Circulating tumour cells; Ex vivo culture; Head and neck cancer; HPV; Metastasis

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD; BLOOD SAMPLING; CANCER RISK; CANCER STAGING; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HYPOXIA; MALE; METASTASIS; MINIMALLY INVASIVE PROCEDURE; NASOPHARYNX TUMOR; OROPHARYNX TUMOR; PILOT STUDY; TUMOR CELL; VERY ELDERLY; CELL COUNT; CELL CULTURE TECHNIQUE; CELL PROLIFERATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HEAD AND NECK TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; TIME FACTOR; TUMOR CELL CULTURE; TUMOR EMBOLISM;

EPIDERMAL GROWTH FACTOR RECEPTOR;

AGED; AGED, 80 AND OVER; CELL COUNT; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PILOT PROJECTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 84991407749     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.11159     Document Type: Article

References (21)

1. Kulasinghe A, Perry C, Jovanovic C, Nelson C, Punyadeera C. Circulating tumour cells in metastatic head and neck cancers. Int J Cancer. 2015; 136:2515-23
2. Warkiani ME, Khoo BL, Wu L, Bhagat AA, Han J, Lim CT. Ultra-fast, label-free isolation of circulating tumor cells from blood using spiral microfluidics. Nat Protoc. 2016; 11:134-48
3. Alix-Panabieres C, Pantel K. Challenges in circulating tumour cell research. Nat Rev Cancer. 2014; 14:623-31
4. Khoo BL, Lee SC, Kumar P, Tan TZ, Warkiani ME, Ow SG, Nandi S, Lim CT, Thiery JP. Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy. Oncotarget. 2015; 6:15578-93. doi: 10.18632/oncotarget.3903
5. Li P, Mao Z, Peng Z, Zhou L, Chen Y, Huang PH, Truica CI, Drabick JJ, El-Deiry WS, Dao M, Suresh S, Huang TJ. Acoustic separation of circulating tumor cells. Proc Natl Acad Sci USA. 2015; 112:4970-5
6. Schmidt H, Kulasinghe A, Perry C, Nelson C, Punyadeera C. A liquid biopsy for head and neck cancers. Expert Rev Mol Diagn. 2016; 16:165-72
7. de Wit S, van Dalum G, Lenferink AT, Tibbe AG, Hiltermann TJ, Groen HJ, van Riken CJ, Terstappen LW. The detection of EpCAM(+) and EpCAM(-) circulating tumor cells. Sci Rep. 2015; 5:12270
8. Gao D, Vela I, Sboner A, Laquinta PJ, Karthaus WR, Gopalan A, Dowling C, Wanjala JN, Undvall EA, Arora VK, Wingvipat J, Kossai M, Ramazanoglu S et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014;159:176-87
9. Wang Z, Wu W, Wang Z, Tang Y, Deng Y, Xu L, Tian J, Shi Q. Ex vivo expansion of circulating lung tumor cells based on one-step microfluidics-based immunomagnetic isolation. Analyst. 2016; 141:3621-5
10. Mazel M, Jacot W, Pantel K, Bartkowiak K, Topart D, Cayrefourcq L, Rossille D, Maudelonde T, Fest T, Alix-Panabieres C. Frequent expression of PDL-1 on ciruclating breast cancer cells. Mol Oncol. 2015; 9:1773-82
11. Hodgkinson CL, Morrow CJ, Li Y, Metcalf RL, Rothwell DG, Trapini F, Polanski R, Burt DJ, Simpson KL, Morris K, Pepper SD, Nonaka D, Greystone A, et al. Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Nat Med 2014; 20:897-903
12. Alix-Panabieres C, Bartkowiak K, Pantel K. Functional studies on circulating and disseminated tumor cells in carcinoma patients. Mol Oncol 2016; 10, 443-9
13. Jatana KR, Balasubramanian P, Lang JC, Yang L, Jatana CA, White E, Agrawal A, Ozer E, Schuller DE, Teknos TN, Chalmers JJ. Significance of Circulating Tumor Cells in Patients With Squamous Cell Carcinoma of the Head and Neck. Arch. Otolaryngol Head Neck Surg. 2010; 136:1274-1279
14. Nichols AC, Lowes LE, Szeto CC, Basmaji J, Dhaliwal S, Chapeskie C, Todorovic B, Read N, Venkatesan V, Hammond A, Palma DA, Winquist E, Ernst S, et al. Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system. Head Neck. 2012; 34:1440-4
15. Wicha MS, Hayes DF. Circulating tumor cells:not all detected cells are bad and not all bad cells are detected. J Clin Oncol. 2011; 29:1508-11
16. Maheswaran S, Haber DA. Ex Vivo Culture of CTCs:An Emerging Resource to Guide Cancer Therapy. Cancer Res. 2015; 75:2411-5
17. Pantel K, Alix-Panabieres C. Cell lines from circulating tumor cells. Oncoscience 2015; 2:815-816. doi: 10.18632/oncoscience.195
18. Cayrefourcq L, Mazard T, Joosse S, Solassol J, Ramos J, Assenat E, Schumacher U, Costes V, Maudelonde T, Pantel K, Alix-Panabieres C. Establishment and characterization of a cell line from human circulating colon cancer cells. Cancer Res. 2015; 75:892-901
19. Zhang L, Ridgway LD, Wetzel MD, Ngo J, Yin W, Kumar D, Goodman JC, Groves MD, Marchetti D. The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci Transl Med. 2013; 5:180
20. Stoecklein NH, Fischer JC, Niederacher D, Terstappen LW. Challenges for CTC-based liquid biopsies:low CTC frequency and diagnostic leukapheresis as a potential solution. Expert Rev Mol Diagn. 2016; 16:147-64
21. Alix-Panabieries C, Pantel K. Clinical applications of circulating tumor cells and circulating tumour DNA as liquid biopsy. Cancer discovery. 2016; 6:479-491